Repurposing Drugs to Tackle Emerging Infectious Diseases - Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, discusses the benefits of repurposing drugs for emerging infectious diseases rather than going down the very long, costly road of developing new ones -
Repurposing Drugs to Tackle Emerging Infectious Diseases
-
Read about repurposing licensed drugs for Zika here:
https://www.contagionlive.com/view/repurposing-licensed-drugs-for-use-against-the-zika-virus
-
Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, discusses the benefits of repurposing drugs for emerging infectious diseases rather than going down the very long, costly road of developing new ones
Comments
0